ADRA2A Blocking Peptide (N-Term)

ADRA2A Blocking Peptide (N-Term)

€363.00
In stock
SKU
AC-BP21754a
Catalog Number: AC-BP21754a
Size: 500 µg
Datasheet
Request Information
Background:
Alpha-2 adrenergic receptors mediate the catecholamine- induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline > clonidine > epinephrine > norepinephrine > phenylephrine > dopamine > p-synephrine > p-tyramine > serotonin = p-octopamine. For antagonists, the rank order is yohimbine > phentolamine = mianserine > chlorpromazine = spiperone = prazosin > propanolol > alprenolol = pindolol.

Other Names:
Alpha-2A adrenergic receptor, Alpha-2 adrenergic receptor subtype C10, Alpha-2A adrenoreceptor, Alpha-2A adrenoceptor, Alpha-2AAR, ADRA2A, ADRA2R, ADRAR

Target/Specificity:
The synthetic peptide sequence is selected from aa 138-152 of HUMAN ADRA2A

Gene Name: ADRA2A (HGNC:281)

Gene ID: 150
Primary Accession: P08913
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:ADRA2A Blocking Peptide (N-Term)